Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
261
-
Total 13F shares, excl. options
-
103M
-
Shares change
-
-1.81M
-
Total reported value, excl. options
-
$2.17B
-
Value change
-
-$38.9M
-
Put/Call ratio
-
4.31
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$20.98
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2013
291 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q4 2013.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 261 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103M shares
.
Largest 10 shareholders include ROYCE & ASSOCIATES LLC (10.8M shares), Capital Research Global Investors (7.62M shares), VANGUARD GROUP INC (4.89M shares), BAILLIE GIFFORD & CO (4.55M shares), Luxor Capital Group, LP (3.3M shares), MUNDER CAPITAL MANAGEMENT (3M shares), Sterling Capital Management LLC (2.62M shares), FIR TREE INC. (2.2M shares), BlackRock Institutional Trust Company, N.A. (2.17M shares), and State Street Corp (1.98M shares).
This table shows the top 261 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.